New Use for Nitisinone - Approved Treatment for Alkaptonuria
Share
A Sigh Of Relief & Hope for People Living with Alkaptonuria
The recent approval of Nitisinone for Alkaptonuria brings hope to people dealing with this rare and debilitating genetic disorder. Previously used for treating Tyrosinemia Type 1, Nitisinone’s expanded use helps Alkaptonuria patients who have struggled with progressive symptoms and limited treatment options. For the first time, there’s a disease-modifying therapy that can potentially slow the progression of Alkaptonuria, offering real relief for patients and their families who’ve been waiting for medication!
Tackling the Harsh Reality of Alkaptonuria
Black Urine disease or Alkaptonuria, is a rare, inherited metabolic disorder affecting about 1 in 250,000 to 1 million people globally, with lifelong symptoms.
The following symptoms of Alkaptonuria should not be ignored, and one must seek medical emergency if they experience any of them -
- Blue, grey, or blackish discoloration of the skin, outer ear, or eyes
- Joint pain and stiffness
- Reduced mobility
- Sleep issues
- Breathing difficulty
- Urine turning black
Today, there are meds that target the root cause, but the high cost and local unavailability make them inaccessible for many patients. Let's explore how to access affordable Alkaptonuria medications without financial strain, easily and legally!
Medicine for AKU - How Nitisinone Works
Nitisinone can now be used to slow the progression of alkaptonuria in adults. It offers hope, slows down symptoms, and can improve quality of life.
How it Works
Nitisinone blocks the production of homogentisic acid by inhibiting an earlier step in the metabolic pathway. It significantly reduces HGA levels and as a result, it slows the long-term damage caused by the disease.
Approval Status
EU
In 2020, the European Medicines Agency (EMA) approved Nitisinone for use in AKU, the first approved disease-modifying treatment for this rare disorder.
USA
Nitisinone (Harliku®) was officially approved by the USFDA on June 19, 2025 for the treatment of adult patients with Alkaptonuria. It is the first and only FDA-approved therapy for this condition
UK
Conditional use / off-label use allowed in some regions.
Australia and New Zealand
Not approved yet
Why Nitisinone Access Remains a Challenge?
Nitisinone offers hope, but remains expensive and inaccessible to many people. In some cases, it is not stocked locally or may be priced far above what patients can afford, especially for long-term use.
Since Alkaptonuria is an ultra-rare disease, most health systems do not subsidize treatment, leaving patients and families to navigate the cost burden alone.
Generic Nitisinone - Safe, Effective, and Affordable
Good news for Alkaptonuria patients is that generic Nitisinone is now available easily in several regulated markets, and it is bioequivalent to the branded version. That means that when compared to the brand-name medicine, the generic version has a similar
- Active ingredient
- Strength and dosage
- Safety profile
- Effectiveness
- 100% Genuine
All at a fraction of the cost and easily accessible!
How Medspartner Supports Access to Affordable Nitisinone
At Medspartner, we aim to bridge the gap between patients and life-changing treatments and source authentic and high-quality Nitisinone from licensed manufacturers that are approved by global regulatory bodies such as the EMA or FDA.
We offer
- Genuine Nitisinone from regulated, verified suppliers.
- Legal delivery for personal use across 40+ countries.
- Full prescription assistance and documentation process.
- Transparent sourcing with no hidden intermediaries.
- End-to-end support for patients with rare diseases.
Is It Legal to Import Nitisinone?
Yes, personal importation of generic Nitisinone is legal in many countries. Most countries allow patients to import prescription medications for personal use in limited quantities with a valid prescription and supporting documents.
MedsPartner helps you source the medicine as per your local laws and supports customers with compliant documentation.
A Step Forward in Treating Alkaptonuria
As the approval of Nitisinone marks a turning point for Alkaptonuria patients, at MedsPartner, we’re committed to making safe, effective, and affordable treatment accessible to patients who need it most.
If you’re seeking Nitisinone or want to learn how to import it legally and affordably, we’re here to help.
Visit medspartner.com or contact our support team to learn more.